Bk virus in kidney transplant: Current concepts, recent advances, and future directions

Rajeev Sharma, Stephanie Tzetzo, Sunil Patel, Mareena Zachariah, Sonakshi Sharma, Thomas Melendy

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

BK virus nephropathy is a challenging clinical problem in kidney transplant recipients with wide range of surveillance and management practices, based on individual experience. BK virus reactivation in kidney transplant recipients can result in BK virus nephropathy and graft loss. The most effective strategy for early diagnosis and treatment of BK virus nephropathy is regular monitoring for BK virus, currently achieved by quantification of viral DNA in blood by quantitative polymerase chain reaction. Immunosuppression reduction remains the mainstay of treatment; however, viral clearance is often followed by acute rejection, likely secondary to a delay between immune reconstitution and viral clearance. Impaired cell-mediated immune response to BK virus has been shown to correlate with progression to BK virus nephropathy, while reconstitution of this response correlates with resolution of nephropathy. There is recent research to support monitoring BK virus-specific cell-mediated immune response as a predictor of disease progression and resolution. In this article, we review the current concepts and recent developments in understanding BK virusassociated disease in the context of kidney transplant and outline areas for future research.

Original languageEnglish (US)
Pages (from-to)377-384
Number of pages8
JournalExperimental and Clinical Transplantation
Volume14
Issue number4
DOIs
StatePublished - Aug 2016

Fingerprint

BK Virus
Viruses
Transplants
Kidney
Direction compound
Practice Management
Viral DNA
Immunosuppression
Disease Progression
Early Diagnosis
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Transplantation

Cite this

Sharma, Rajeev ; Tzetzo, Stephanie ; Patel, Sunil ; Zachariah, Mareena ; Sharma, Sonakshi ; Melendy, Thomas. / Bk virus in kidney transplant : Current concepts, recent advances, and future directions. In: Experimental and Clinical Transplantation. 2016 ; Vol. 14, No. 4. pp. 377-384.
@article{76ae1d9aa235432ca28ca36ef5fa887a,
title = "Bk virus in kidney transplant: Current concepts, recent advances, and future directions",
abstract = "BK virus nephropathy is a challenging clinical problem in kidney transplant recipients with wide range of surveillance and management practices, based on individual experience. BK virus reactivation in kidney transplant recipients can result in BK virus nephropathy and graft loss. The most effective strategy for early diagnosis and treatment of BK virus nephropathy is regular monitoring for BK virus, currently achieved by quantification of viral DNA in blood by quantitative polymerase chain reaction. Immunosuppression reduction remains the mainstay of treatment; however, viral clearance is often followed by acute rejection, likely secondary to a delay between immune reconstitution and viral clearance. Impaired cell-mediated immune response to BK virus has been shown to correlate with progression to BK virus nephropathy, while reconstitution of this response correlates with resolution of nephropathy. There is recent research to support monitoring BK virus-specific cell-mediated immune response as a predictor of disease progression and resolution. In this article, we review the current concepts and recent developments in understanding BK virusassociated disease in the context of kidney transplant and outline areas for future research.",
author = "Rajeev Sharma and Stephanie Tzetzo and Sunil Patel and Mareena Zachariah and Sonakshi Sharma and Thomas Melendy",
year = "2016",
month = "8",
doi = "10.6002/ect.2016.0030",
language = "English (US)",
volume = "14",
pages = "377--384",
journal = "Experimental and Clinical Transplantation",
issn = "1544-1873",
publisher = "Cambridge University Press",
number = "4",

}

Sharma, R, Tzetzo, S, Patel, S, Zachariah, M, Sharma, S & Melendy, T 2016, 'Bk virus in kidney transplant: Current concepts, recent advances, and future directions', Experimental and Clinical Transplantation, vol. 14, no. 4, pp. 377-384. https://doi.org/10.6002/ect.2016.0030

Bk virus in kidney transplant : Current concepts, recent advances, and future directions. / Sharma, Rajeev; Tzetzo, Stephanie; Patel, Sunil; Zachariah, Mareena; Sharma, Sonakshi; Melendy, Thomas.

In: Experimental and Clinical Transplantation, Vol. 14, No. 4, 08.2016, p. 377-384.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Bk virus in kidney transplant

T2 - Current concepts, recent advances, and future directions

AU - Sharma, Rajeev

AU - Tzetzo, Stephanie

AU - Patel, Sunil

AU - Zachariah, Mareena

AU - Sharma, Sonakshi

AU - Melendy, Thomas

PY - 2016/8

Y1 - 2016/8

N2 - BK virus nephropathy is a challenging clinical problem in kidney transplant recipients with wide range of surveillance and management practices, based on individual experience. BK virus reactivation in kidney transplant recipients can result in BK virus nephropathy and graft loss. The most effective strategy for early diagnosis and treatment of BK virus nephropathy is regular monitoring for BK virus, currently achieved by quantification of viral DNA in blood by quantitative polymerase chain reaction. Immunosuppression reduction remains the mainstay of treatment; however, viral clearance is often followed by acute rejection, likely secondary to a delay between immune reconstitution and viral clearance. Impaired cell-mediated immune response to BK virus has been shown to correlate with progression to BK virus nephropathy, while reconstitution of this response correlates with resolution of nephropathy. There is recent research to support monitoring BK virus-specific cell-mediated immune response as a predictor of disease progression and resolution. In this article, we review the current concepts and recent developments in understanding BK virusassociated disease in the context of kidney transplant and outline areas for future research.

AB - BK virus nephropathy is a challenging clinical problem in kidney transplant recipients with wide range of surveillance and management practices, based on individual experience. BK virus reactivation in kidney transplant recipients can result in BK virus nephropathy and graft loss. The most effective strategy for early diagnosis and treatment of BK virus nephropathy is regular monitoring for BK virus, currently achieved by quantification of viral DNA in blood by quantitative polymerase chain reaction. Immunosuppression reduction remains the mainstay of treatment; however, viral clearance is often followed by acute rejection, likely secondary to a delay between immune reconstitution and viral clearance. Impaired cell-mediated immune response to BK virus has been shown to correlate with progression to BK virus nephropathy, while reconstitution of this response correlates with resolution of nephropathy. There is recent research to support monitoring BK virus-specific cell-mediated immune response as a predictor of disease progression and resolution. In this article, we review the current concepts and recent developments in understanding BK virusassociated disease in the context of kidney transplant and outline areas for future research.

UR - http://www.scopus.com/inward/record.url?scp=84982921347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982921347&partnerID=8YFLogxK

U2 - 10.6002/ect.2016.0030

DO - 10.6002/ect.2016.0030

M3 - Review article

C2 - 27267780

AN - SCOPUS:84982921347

VL - 14

SP - 377

EP - 384

JO - Experimental and Clinical Transplantation

JF - Experimental and Clinical Transplantation

SN - 1544-1873

IS - 4

ER -